Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.
Riley Exploration Permian $130M Debt Financing with Truist Bank
Riley Exploration Permian, Inc. borrowed $130 million under its existing credit facility with Truist Bank to voluntarily prepay in full its 10.50% Senior Unsecured Notes due 2028. The refinancing leaves the company's total debt substantially unchanged while satisfying and discharging all obligations under the previous Note Purchase Agreement.
MicroVision held a virtual business update event to reaffirm its 2026 revenue guidance of $10 million to $15 million and project a doubling of revenue in 2027. Management outlined a 'Lidar 2.0' strategy focused on commercial execution across industrial, defense, and AI data center markets while planning a significant reduction in cash burn for 2027.
Advasa Holdings appointed William Witherspoon as its new Chief Financial Officer, effective October 6, 2026. Mr. Witherspoon, who previously served as an independent director, will receive an annual base salary of $200,000 and is eligible for discretionary bonuses and equity grants. He succeeds CEO Grady Ryther, who had been serving as interim CFO since August 2026.
Medicus Pharma Ltd. announced a fifty-to-one (1-for-50) reverse stock split of its common shares effective October 12, 2026. The consolidation is intended to increase the per-share bid price to regain compliance with Nasdaq's minimum bid price requirement for continued listing. The split was previously authorized by shareholders at the company's annual meeting on June 3, 2026.
Ocean Power Technologies announced that Robert Powers departed as CFO effective September 30, 2026, and will remain through October 14, 2026, to assist with the transition. The company has appointed Victoria Hay from Flexible Consulting, LLC as interim Chief Financial Officer while conducting a search for a permanent successor. Mr. Powers will receive six months of base salary and his fiscal 2026 bonus as part of a severance agreement.
Unusual Machines, Inc. held its 2026 Annual Meeting of Stockholders on October 5, 2026, where shareholders elected five directors and ratified Ernst & Young LLP as the independent auditor for the fiscal year ending December 31, 2026. Stockholders also approved a warrant grant to the company's Chief Executive Officer and an adjournment proposal, though adjournment was not necessary as all primary proposals passed.
Matternet, Inc. entered into a separation agreement with outgoing Chief Financial Officer Jason Secore, whose employment ended on September 29, 2026. Under the agreement, Mr. Secore will receive a cash payment of $156,146 and an extension of the post-termination exercise period for his equity awards. CEO Andreas Raptopoulos is currently serving as the interim CFO while the company searches for a permanent successor.
Twist Bioscience CEO Emily M. Leproust Sells $910K of Stock
Emily M. Leproust, CEO, sold 4,503 shares of Twist Bioscience Corp at $200.44 to $206.84 a share (average $202.10) in 7 transactions, worth $910K in total on Oct 5, 2026. Shares held after the trade: 562,805 (-0.0%).
Applied Optoelectronics *** See Remarks Shu-Hua (Joshua) Yeh Sells $720K of Stock
Shu-Hua (Joshua) Yeh, *** See Remarks, sold 6,000 shares of Applied Optoelectronics, Inc. at $120.03 a share, worth $720K in total on Oct 5, 2026. Shares held after the trade: 371,498 (-1.6%).
SOPHiA Genetics Chief People Officer Manuela Valente Sells $34.5K of Stock
Manuela Valente, Chief People Officer, sold 4,240 shares of SOPHiA Genetics SA at $8.13 a share, worth $34.5K in total on Oct 5, 2026. Shares held after the trade: 206,210 (-2.0%).
SOPHiA Genetics CLO Well Daan Van Sells $50.1K of Stock
Well Daan Van, CLO, sold 6,168 shares of SOPHiA Genetics SA at $8.12 a share, worth $50.1K in total on Oct 5, 2026. Shares held after the trade: 332,716 (-1.8%).
SOPHiA Genetics CTO Abhimanyu Verma Sells $42.9K of Stock
Abhimanyu Verma, CTO, sold 5,284 shares of SOPHiA Genetics SA at $8.12 a share, worth $42.9K in total on Oct 5, 2026. Shares held after the trade: 166,887 (-3.1%).
SOPHiA Genetics CMO Philippe Menu Sells $60.1K of Stock
Philippe Menu, CMO, sold 7,394 shares of SOPHiA Genetics SA at $8.13 a share, worth $60.1K in total on Oct 5, 2026. Shares held after the trade: 200,993 (-3.5%).
SOPHiA Genetics CFO George Cardoza Sells $12.9K of Stock
George Cardoza, CFO, sold 1,592 shares of SOPHiA Genetics SA at $8.10 a share, worth $12.9K in total on Oct 5, 2026. Shares held after the trade: 306,726 (-0.5%).
SOPHiA Genetics Executive Chairman Jurgi Camblong Sells $327K of Stock
Jurgi Camblong, Executive Chairman, sold 40,172 shares of SOPHiA Genetics SA at $8.13 a share, worth $327K in total on Oct 5, 2026. Shares held after the trade: 3,395,650 (-1.2%).
SOPHiA Genetics CEO Ross Muken Sells $80K of Stock
Ross Muken, CEO, sold 9,838 shares of SOPHiA Genetics SA at $8.13 a share, worth $80K in total on Oct 5, 2026. Shares held after the trade: 660,391 (-1.5%).
SOPHiA Genetics CSO Zhenyu Xu Sells $60.1K of Stock
Zhenyu Xu, CSO, sold 7,394 shares of SOPHiA Genetics SA at $8.12 a share, worth $60.1K in total on Oct 5, 2026. Shares held after the trade: 545,493 (-1.3%).
Artiva Biotherapeutics CEO Fred Aslan Sells $169K of Stock
Fred Aslan, CEO, sold 23,463 shares of Artiva Biotherapeutics, Inc. at $7.20 a share, worth $169K in total on Oct 6, 2026. Shares held after the trade: 1,519,606 (-1.5%).
GridAI Technologies Equity Investment of $3.5M in Pronghorn Resources, LLC
GridAI Technologies Corp. entered into a Second Amended and Restated Secured Convertible Note with Pronghorn Resources, LLC, providing an additional $536,000 loan. This brings the total aggregate principal amount invested by GridAI into Pronghorn to $3.5 million, secured by an amended security agreement.
North Haven Net REIT sold an aggregate of 2,835,825 common shares in its continuous private offering for approximately $59.6 million. The sale included Class S, Class F-I, Class I, and Class E common shares at the company's most recently determined net asset value per share.
Intellinetics Insider Robert Taglich Buys $20K of Stock
Robert Taglich bought 4,000 shares of Intellinetics, Inc. at $5.00 a share, worth $20K in total on Oct 6, 2026. Shares held after the trade: 459,338 (+0.9%).
Amylyx Pharmaceuticals Director George M. Milne Jr. Sells $831K of Stock
George M. Milne Jr., Director, sold 30,000 shares of Amylyx Pharmaceuticals, Inc. at $27.70 a share, worth $831K in total on Oct 5, 2026. Shares held after the trade: 782,881 (-3.7%).
Alignment Healthcare CMO Hyong Kim Sells $270K of Stock
Hyong Kim, CMO, sold 32,479 shares of Alignment Healthcare, Inc. at $8.30 a share, worth $270K in total on Oct 6, 2026. Shares held after the trade: 299,271 (-9.8%).
Emergent BioSolutions Insider Donald W. DeGolyer Sells $126K of Stock
Donald W. DeGolyer sold 17,800 shares of Emergent BioSolutions Inc. at $7.09 a share, worth $126K in total on Oct 7, 2026. Shares held after the trade: 111,921 (-13.7%).
Fatpipe $6M Debt Financing with KeyBank National Association
FatPipe, Inc. entered into a $4.5 million secured term loan and a $1.5 million secured revolving line of credit with KeyBank. The proceeds from the term loan were used to refinance an existing SBA loan with Fortis Bank, resulting in an expected 110 basis point reduction in the company's annual borrowing rate.
Copper Property CTL Pass Through Trust announced a monthly cash distribution of $0.076725 per trust certificate. The distribution is payable on October 13, 2026, to certificateholders of record as of October 12, 2026. The filing also includes the Trust's monthly reporting package for the period ending September 30, 2026.
Ares Core Infrastructure Fund Capital Raise of $768M
Ares Core Infrastructure Fund agreed to sell multiple classes of common shares for an aggregate purchase price of $767.8 million in its October 2026 monthly closing. The shares were sold in an unregistered private placement exempt from registration requirements, with the price per share tied to the fund's net asset value as of September 30, 2026.
Origin Real Estate Credit Fund Insider Lawrence B. Stoller Buys $10K of Stock
Lawrence B. Stoller bought 1,019 shares of Origin Real Estate Credit Fund at $9.81 a share, worth $10K in total on Oct 5, 2026. Shares held after the trade: 3,522 (+40.7%).
Tessera Defense and Homeland Security entered into a formal employment agreement with CEO Michael Oster, who has served without pay since March 2026. The agreement includes a monthly salary of approximately $18,000, a 50% cash bonus target, and a significant equity package consisting of 1 million RSUs, 1 million stock options, and performance-based shares tied to EBITDA-per-share targets for 2027 and 2028.
T3 Defense Inc. appointed Shlomo Zakai as Chief Financial Officer, effective October 5, 2026. Under a consulting agreement, Mr. Zakai will receive a monthly fee of $13,000 plus VAT for his services. He previously served as CFO of Duke Robotics Corp. and Water IO Ltd.